Cite

HARVARD Citation

    Arribas, A. et al. (n.d.). MECHANISMS OF SECONDARY RESISTANCE TO IDELALISIB IN MARGINAL ZONE LYMPHOMA. Hematological oncology. p. 319. [Online]. 
  
Back to record